Detalhe da pesquisa
1.
Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice.
Rheumatol Ther
; 8(1): 529-539, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638132
2.
Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry.
Arthritis Res Ther
; 23(1): 236, 2021 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496952
3.
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
J Immunother Cancer
; 9(4)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879601
4.
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.
Nat Cancer
; 1(12): 1204-1217, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121932
5.
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.
J Clin Oncol
; 37(9): 693-702, 2019 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30726175
6.
Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study.
Rheumatol Ther
; 5(1): 215-229, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29322372
7.
Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry.
Rheumatol Ther
; 4(2): 375-389, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28840531